The aim of this work is to analyze the TPMT-VNTR in ALL pediatric patients from Uruguay and determine its association with 6-MP hematological toxicity (measured as the number of leukopenia events and 6-MP cumulative dose) in the maintenance phase; taking individual genetic ancestry into account. The gene discussed is TPMT; the disease is Decreased total leukocyte count.